Error: Could not add to watchlist. X
+ Watchlist

Vertex Pharmaceuticals Inc

VRTX:US
NASDAQ GS
129.54
USD
0.31
0.24%
As of 10:29 AM EDT 6/28/2017
Open
129.69
Day Range
128.94 - 130.16
Volume
209,827
Previous Close
129.23
52Wk Range
71.46 - 137.26
1 Yr Return
55.19%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
129.69
Day Range
128.94 - 130.16
Volume
209,827
Previous Close
129.23
52Wk Range
71.46 - 137.26
1 Yr Return
55.19%
YTD Return
75.84%
Current P/E Ratio (TTM)
178.48
Earnings per Share (USD) (TTM)
0.72
Market Cap (b USD)
32.187
Shares Outstanding (m)
249.069
Price/Sales (TTM)
15.74
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.74%
% Price Change
+0.74%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharmaceuticals serves the healthcare sector internationally.
Address
50 Northern Avenue
Boston, MA 02210
United States
Phone
1-617-341-6100
  • Jeffrey M Leiden "Jeff"
    Chairman/President/CEO
  • Ian F Smith
    Exec VP/CFO/COO
  • Michael J Parini
    Exec VP/Chief Legal & Administrative Ofcr
  • Amit K Sachdev
    Exec VP/Chief Regulatory Ofcr
  • Stuart A Arbuckle
    Exec VP/Chief Commercial Ofcr
Show More